Found: 8
Select item for more details and to access through your institution.
Outcome of Graves’ Orbitopathy after Total Thyroid Ablation and Glucocorticoid Treatment: Follow-Up of a Randomized Clinical Trial.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study.
- Published in:
- Thyroid, 2018, v. 28, n. 3, p. 386, doi. 10.1089/thy.2017.0430
- By:
- Publication type:
- Article
Intravenous glucocorticoid therapy for Graves' ophthalmopathy and acute liver damage: an epidemiological study.
- Published in:
- European Journal of Endocrinology, 2015, v. 172, n. 3, p. 269, doi. 10.1530/EJE-14-0712
- By:
- Publication type:
- Article
Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy.
- Published in:
- Thyroid, 2015, v. 25, n. 7, p. 846, doi. 10.1089/thy.2015.0061
- By:
- Publication type:
- Article
Role of the Underlying Thyroid Disease on the Phenotype of Graves' Orbitopathy in a Tertiary Referral Center.
- Published in:
- Thyroid, 2015, v. 25, n. 3, p. 347, doi. 10.1089/thy.2014.0475
- By:
- Publication type:
- Article
Spontaneous Improvement of Untreated Mild Graves' Ophthalmopathy: Rundle's Curve Revisited.
- Published in:
- Thyroid, 2014, v. 24, n. 1, p. 60, doi. 10.1089/thy.2013.0240
- By:
- Publication type:
- Article
Thyroid Volume and Severity of Graves' Orbitopathy.
- Published in:
- Thyroid, 2013, v. 23, n. 1, p. 97, doi. 10.1089/thy.2012.0379
- By:
- Publication type:
- Article
Neoadjuvant treatment with lenvatinib and pembrolizumab in a BRAF V600E-mutated anaplastic thyroid cancer: a case report.
- Published in:
- Frontiers in Endocrinology, 2024, p. 01, doi. 10.3389/fendo.2024.1389294
- By:
- Publication type:
- Article